Nifty
:
23997.55
Sensex
:
76913.50
-180.10 (-0.74%)
-582.86 (-0.75%)
Nifty
Sensex
:
:
23997.55
76913.50
-180.10 (-0.74%)
-582.86 (-0.75%)

Acutaas Chemicals Ltd.

Pharmaceuticals & Drugs

Rating :
77/99

BSE: 543349 | NSE: ACUTAAS

NSE BSE
2594.10
30-Apr-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2516.3
  •  2710
  •  2486
  •  2502.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2668458
  •  6895306363.7
  •  2710
  •  1059

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 21,258.25
  • 59.67
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,059.90
  • 0.10%
  • 13.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.66%
  • 1.50%
  • 23.21%
  • FII
  • DII
  • Others
  • 19.48%
  • 17.12%
  • 6.03%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.68
  • 24.21
  • 17.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.00
  • 23.69
  • 13.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.77
  • 24.06
  • 23.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 62.55
  • 68.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.37
  • 7.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 39.18
  • 39.84

Earnings Forecasts:

(Updated: 02-05-2026)
Description
2024
2025
2026
2027
Adj EPS
19.81
42.91
52.79
61.49
P/E Ratio
130.95
60.45
49.14
42.19
Revenue
1006.88
1315.76
1695.16
2179.59
EBITDA
232.07
434.35
541.33
697.69
Net Income
158.71
315.54
388.35
508.47
ROA
12
17.84
18.84
19.64
P/B Ratio
16.22
13.14
9.03
7.21
ROE
16
21.24
21.3
22.54
FCFF
-71.7
-51.9
181.13
240.56
FCFF Yield
-0.36
-0.26
0.91
1.2
Net Debt
-235.99
-153.5
-321.07
-546.22
BVPS
159.97
197.43
287.4
359.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
432.75
308.48
40.28%
393.18
274.99
42.98%
306.20
246.73
24.10%
207.24
176.67
17.30%
Expenses
249.24
223.53
11.50%
242.53
206.32
17.55%
210.87
197.80
6.61%
156.33
147.15
6.24%
EBITDA
183.51
84.96
116.00%
150.65
68.67
119.38%
95.32
48.93
94.81%
50.91
29.52
72.46%
EBIDTM
42.41%
27.54%
38.32%
24.97%
31.13%
19.83%
24.57%
16.71%
Other Income
11.11
5.78
92.21%
4.70
1.67
181.44%
9.84
8.44
16.59%
15.94
1.04
1,432.69%
Interest
1.19
0.60
98.33%
0.86
0.69
24.64%
0.58
0.50
16.00%
0.64
4.43
-85.55%
Depreciation
9.63
7.30
31.92%
9.82
6.32
55.38%
8.40
6.83
22.99%
8.13
6.18
31.55%
PBT
183.80
82.84
121.87%
144.67
63.33
128.44%
96.18
50.04
92.21%
58.08
19.96
190.98%
Tax
49.52
20.12
146.12%
38.45
17.89
114.92%
24.32
12.47
95.03%
14.07
5.26
167.49%
PAT
134.28
62.72
114.09%
106.22
45.45
133.71%
71.85
37.57
91.24%
44.01
14.69
199.59%
PATM
31.03%
20.33%
27.02%
16.53%
23.47%
15.23%
21.24%
8.31%
EPS
16.09
3.82
321.20%
13.19
5.49
140.26%
8.82
4.56
93.42%
5.41
1.70
218.24%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,339.37
1,006.88
717.47
616.73
520.13
340.61
239.64
238.51
188.22
160.26
153.70
Net Sales Growth
33.02%
40.34%
16.33%
18.57%
52.71%
42.13%
0.47%
26.72%
17.45%
4.27%
 
Cost Of Goods Sold
565.96
552.18
411.69
330.89
272.83
179.68
128.91
148.43
112.95
95.00
91.50
Gross Profit
773.41
454.69
305.79
285.84
247.30
160.92
110.73
90.08
75.27
65.27
62.21
GP Margin
57.74%
45.16%
42.62%
46.35%
47.55%
47.24%
46.21%
37.77%
39.99%
40.73%
40.47%
Total Expenditure
858.97
774.80
588.98
494.13
414.96
260.45
198.63
196.43
157.70
137.13
135.51
Power & Fuel Cost
-
30.12
25.82
22.28
21.40
5.26
4.54
4.14
1.27
1.00
1.26
% Of Sales
-
2.99%
3.60%
3.61%
4.11%
1.54%
1.89%
1.74%
0.67%
0.62%
0.82%
Employee Cost
-
83.66
63.11
48.84
41.37
21.01
17.81
11.75
9.89
7.38
7.02
% Of Sales
-
8.31%
8.80%
7.92%
7.95%
6.17%
7.43%
4.93%
5.25%
4.61%
4.57%
Manufacturing Exp.
-
51.77
47.35
46.98
49.66
41.32
34.60
16.94
19.87
15.42
14.41
% Of Sales
-
5.14%
6.60%
7.62%
9.55%
12.13%
14.44%
7.10%
10.56%
9.62%
9.38%
General & Admin Exp.
-
19.23
12.97
9.93
7.30
4.46
4.72
5.71
8.59
13.68
15.24
% Of Sales
-
1.91%
1.81%
1.61%
1.40%
1.31%
1.97%
2.39%
4.56%
8.54%
9.92%
Selling & Distn. Exp.
-
29.63
19.88
26.49
19.92
7.01
5.79
6.04
3.97
3.92
5.36
% Of Sales
-
2.94%
2.77%
4.30%
3.83%
2.06%
2.42%
2.53%
2.11%
2.45%
3.49%
Miscellaneous Exp.
-
8.22
8.15
8.71
2.49
1.72
2.26
3.43
1.16
0.74
5.36
% Of Sales
-
0.82%
1.14%
1.41%
0.48%
0.50%
0.94%
1.44%
0.62%
0.46%
0.47%
EBITDA
480.39
232.08
128.49
122.60
105.17
80.16
41.01
42.08
30.52
23.13
18.19
EBITDA Margin
35.87%
23.05%
17.91%
19.88%
20.22%
23.53%
17.11%
17.64%
16.22%
14.43%
11.83%
Other Income
41.59
16.93
7.49
4.32
2.76
1.38
2.84
0.38
2.96
0.21
2.87
Interest
3.27
6.22
5.94
2.41
6.41
5.62
5.59
4.75
3.23
3.30
2.56
Depreciation
35.98
26.62
16.06
12.34
10.08
4.19
3.52
2.60
1.91
1.37
0.80
PBT
482.73
216.16
113.99
112.17
91.45
71.73
34.75
35.11
28.35
18.68
17.70
Tax
126.36
55.75
33.19
28.88
19.50
17.73
7.28
11.81
9.85
6.63
5.04
Tax Rate
26.18%
25.79%
40.52%
25.75%
21.32%
24.72%
20.95%
33.64%
34.74%
35.49%
28.47%
PAT
356.36
158.72
42.78
83.29
71.95
54.00
27.47
23.30
18.50
12.05
12.66
PAT before Minority Interest
356.25
160.42
48.71
83.29
71.95
54.00
27.47
23.30
18.50
12.05
12.66
Minority Interest
-0.11
-1.70
-5.93
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
26.61%
15.76%
5.96%
13.51%
13.83%
15.85%
11.46%
9.77%
9.83%
7.52%
8.24%
PAT Growth
122.13%
271.01%
-48.64%
15.76%
33.24%
96.58%
17.90%
25.95%
53.53%
-4.82%
 
EPS
43.51
19.38
5.22
10.17
8.79
6.59
3.35
2.84
2.26
1.47
1.55

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
1,309.63
674.00
593.96
522.27
166.93
111.81
82.22
57.68
38.99
27.42
Share Capital
40.93
36.88
36.44
36.44
31.50
10.50
10.50
1.50
1.50
1.50
Total Reserves
1,268.59
634.81
557.52
485.84
135.43
101.31
71.72
56.18
37.49
25.92
Non-Current Liabilities
26.93
127.98
10.13
7.29
80.29
25.46
25.37
32.73
15.09
15.21
Secured Loans
0.00
113.64
0.63
0.59
71.82
12.59
11.60
28.10
14.03
13.94
Unsecured Loans
0.00
0.00
0.00
0.00
0.82
7.31
10.50
3.68
0.47
2.05
Long Term Provisions
2.55
1.32
0.68
0.44
4.37
2.44
1.14
0.98
0.63
0.37
Current Liabilities
202.25
285.17
162.85
129.32
166.04
94.61
105.56
65.00
54.82
48.60
Trade Payables
156.05
134.61
142.05
118.42
84.78
51.45
68.39
47.76
38.43
28.42
Other Current Liabilities
13.48
64.78
6.64
4.88
34.62
8.84
10.52
3.36
4.99
5.07
Short Term Borrowings
8.18
72.59
2.77
0.00
44.53
33.92
26.14
9.48
9.06
11.49
Short Term Provisions
24.54
13.20
11.39
6.02
2.12
0.41
0.51
4.40
2.34
3.63
Total Liabilities
1,549.26
1,095.91
766.94
658.88
413.26
231.88
213.15
155.41
108.90
91.23
Net Block
570.39
427.16
258.95
204.53
186.31
85.19
78.78
31.54
27.76
18.48
Gross Block
651.64
481.95
297.69
231.14
202.83
97.78
90.97
41.13
35.45
24.81
Accumulated Depreciation
81.25
54.79
38.74
26.60
16.52
12.59
12.20
9.60
7.69
6.32
Non Current Assets
757.63
602.60
309.81
229.31
190.83
104.93
85.41
66.45
42.30
24.90
Capital Work in Progress
130.28
125.42
29.80
2.96
0.20
11.71
1.96
30.32
11.42
3.77
Non Current Investment
0.20
0.20
1.65
1.71
1.43
1.73
1.64
2.55
1.43
1.37
Long Term Loans & Adv.
55.88
48.59
17.20
14.23
1.65
2.68
2.24
0.76
0.54
0.48
Other Non Current Assets
0.88
1.23
2.21
5.87
1.25
3.63
0.79
1.28
1.15
0.80
Current Assets
791.64
493.30
457.13
429.57
216.23
121.04
124.10
87.19
66.48
66.17
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
179.94
156.73
119.17
112.17
60.36
52.34
38.67
27.39
19.72
19.64
Sundry Debtors
290.49
206.35
230.26
163.70
120.69
56.40
76.09
49.97
36.49
36.30
Cash & Bank
248.93
53.31
58.67
99.55
2.68
3.82
0.49
1.17
3.58
0.51
Other Current Assets
72.27
4.44
7.95
11.09
32.49
8.47
8.85
8.67
6.68
9.72
Short Term Loans & Adv.
69.20
72.47
41.08
43.05
20.76
8.31
8.53
8.54
6.29
9.48
Net Current Assets
589.39
208.13
294.28
300.25
50.19
26.42
18.54
22.19
11.66
17.57
Total Assets
1,549.27
1,095.90
766.94
658.88
413.26
231.89
213.16
155.41
108.90
91.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
118.34
125.17
65.53
-11.93
27.96
27.08
8.46
28.54
9.86
PBT
216.16
81.90
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Adjustment
18.92
49.79
14.09
13.64
8.02
10.17
4.43
4.07
2.66
Changes in Working Capital
-70.01
17.82
-36.28
-94.21
-37.61
-9.44
-16.54
12.56
-7.53
Cash after chg. in Working capital
165.08
149.52
89.98
10.88
42.14
35.49
16.24
35.31
12.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-46.74
-24.35
-24.45
-22.81
-14.18
-8.41
-7.78
-6.78
-2.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-223.94
-365.39
-33.04
-120.72
-101.21
-23.94
-25.32
-18.61
-14.23
Net Fixed Assets
-170.91
-245.28
-83.19
-30.11
-90.85
-31.67
-21.20
-14.99
Net Investments
-2.07
-34.28
-0.05
-0.16
-5.35
-6.72
-5.77
-4.04
Others
-50.96
-85.83
50.20
-90.45
-5.01
14.45
1.65
0.42
Cash from Financing Activity
261.12
239.36
-12.25
140.26
72.11
0.19
14.62
-7.11
4.37
Net Cash Inflow / Outflow
155.52
-0.86
20.24
7.61
-1.14
3.33
-2.23
2.82
-0.01
Opening Cash & Equivalents
29.70
30.53
10.30
2.68
3.82
0.49
3.14
0.32
0.33
Closing Cash & Equivalent
185.22
29.70
30.53
10.30
2.68
3.82
0.90
3.14
0.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
79.98
91.06
163.01
143.34
17.01
106.49
372.75
259.14
181.71
ROA
12.13%
5.23%
11.68%
13.42%
16.74%
12.34%
13.99%
12.04%
13.87%
ROE
16.19%
7.70%
14.92%
21.07%
39.63%
28.31%
39.03%
36.44%
46.43%
ROCE
20.14%
11.81%
20.45%
23.85%
33.01%
26.25%
38.24%
35.91%
35.54%
Fixed Asset Turnover
1.78
1.84
2.33
2.40
2.27
2.54
4.92
5.32
6.20
Receivable days
90.06
111.06
116.58
99.79
94.89
100.90
83.83
82.89
86.20
Inventory Days
61.02
70.18
68.46
60.54
60.39
69.31
45.68
44.82
46.64
Payable days
96.06
122.64
143.66
135.92
138.36
169.65
99.64
97.78
86.73
Cash Conversion Cycle
55.02
58.60
41.38
24.41
16.92
0.56
29.87
29.93
46.11
Total Debt/Equity
0.01
0.32
0.01
0.00
0.85
0.53
0.78
0.68
1.09
Interest Cover
35.76
14.79
47.50
15.27
13.77
7.22
9.79
6.67
7.92

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Acutaas Chemicals - Quarterly Results
    1st May 2026, 00:00 AM

    Read More
  • Acutaas Chemicals’ arm buys 75% stake in JV company in South Korea
    12th Feb 2026, 14:42 PM

    Indichem Inc. has become a step-down subsidiary of the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.